Answers are grounded in this paper and cite their sources.
Objective NA. Background Chronic granulomatous herpes simplex encephalitis (CG-HSVE) is a rare complication following primary herpes simplex virus (HSV) encephalitis. Herein, we highlight the extensive diagnostic workup leading to the identification of CG-HSVE, and the unique treatment approach implemented. Design/Methods NA. Results Herein, we present a 13-month-old female with intractable seizures and progressive neurologic decline five months after an initial HSV encephalitis diagnosis (confirmed by PCR) and adequate prophylactic oral acyclovir treatment. Imaging demonstrated a unique and striking pattern of confluent parieto-occipital lesions with irregular nodular/gyriform enhancement and vasogenic edema. Extensive investigations culminating in a brain biopsy demonstrated chronic granulomatous encephalitis (with discrete well-formed necrotizing/non-necrotizing granulomas). HSV-1 DNA was identified in parenchymal tissue without viral inclusions or immunoreactive antigens. She was treated with acyclovir, high dose corticosteroids, intravenous immunoglobulin, and mycophenolate mofetil, resulting in marked clinical and radiologic improvement. Conclusions CG-HSVE remains a rare entity primarily presenting in the pediatric population– with only fifteen reported cases in the literature; this leads to delays in identification and variable management amongst studies. It is characterized by progressive neurological and radiographic deterioration, intractable seizures, and a characteristic MRI. In all cases, including our own, histopathology was necessary to reach a CG-HSVE diagnosis. Prognosis is variable ranging from good recovery to fatality (in four of the fifteen patients). Earlier identification and treatment are necessary given the significantly variable prognosis of this disease. CG-HSVE pathophysiology is not well understood, possibly mediated by type I interferons and inflammasome activation. Given this uncertain we argue that a two-pronged treatment approach aimed at treating both chronic HSV infection and post-infectious granulomatous inflammation is warranted.
No takes yet. Share an insight, caveat, or question.
Yong et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: